» Articles » PMID: 20597830

ROSSO-in-praxi: a Self-monitoring of Blood Glucose-structured 12-week Lifestyle Intervention Significantly Improves Glucometabolic Control of Patients with Type 2 Diabetes Mellitus

Overview
Date 2010 Jul 6
PMID 20597830
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As healthy diet and physical activity can improve glucometabolic control in patients with type 2 diabetes, lifestyle changes should be the basis for each therapy. The only tool to visualize immediate effects of food pattern and exercise on blood glucose levels is self-monitoring of blood glucose (SMBG). Therefore, the aim of the 12-week lifestyle intervention ROSSO-in-praxi was to evaluate the impact of an SMBG-structured motivation and education program on glucometabolic and health parameters in diabetes patients not treated with insulin.

Methods: Participants (n = 405) generated a seven-point blood glucose diurnal profile every 4 weeks, including actual weight, waist circumference, and steps/day. At baseline and the end of the study, glycated hemoglobin A1c (HbA1c), blood pressure, and cholesterol levels, lifestyle changes, and well-being (SF36 and Center for Epidemiologic Studies Depression Scale questionnaires) were assessed.

Results: Three hundred twenty-seven participants (81%) completed the program and significantly improved quality of diet and physical activity, accompanied by an increase of >2,300 steps/day. Participants significantly reduced weight, body mass index, waist circumference, blood glucose, blood pressure, low-density lipoprotein cholesterol, and HbA1c by 0.3% (all P < 0.001), accompanied by increased physical and mental health and reduced depression measurements. Weight loss was significantly associated with overall improvements of glucometabolic and health parameters and mean reduction of 0.05% HbA1c/kg.

Conclusions: The evaluated SMBG-structured lifestyle intervention is applicable to motivate individuals with type 2 diabetes for lifestyle changes. Integration of this short-term, highly motivational, and low-cost intervention into basic therapy for patients without insulin therapy could strengthen patient empowerment in order to change lifestyle and to improve glucometabolic and general health.

Citing Articles

The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis.

Holmes-Truscott E, Baptista S, Ling M, Collins E, Ekinci E, Furler J Front Clin Diabetes Healthc. 2023; 4:1177030.

PMID: 37153750 PMC: 10157033. DOI: 10.3389/fcdhc.2023.1177030.


Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study.

Su B, Chen Y, Shen X, Guo J, Ding Y, Ma X J Med Internet Res. 2023; 25:e38680.

PMID: 37097724 PMC: 10170357. DOI: 10.2196/38680.


Utilizing Technology-Enabled Intervention to Improve Blood Glucose Self-Management Outcome in Type 2 Diabetic Patients Initiated on Insulin Therapy: A Retrospective Real-World Study.

Lin J, Li X, Jiang S, Ma X, Yang Y, Zhou Z Int J Endocrinol. 2020; 2020:7249782.

PMID: 33224195 PMC: 7671790. DOI: 10.1155/2020/7249782.


Weight Reduction by the Low-Insulin-Method-A Randomized Controlled Trial.

Rohling M, Martin K, Ellinger S, Schreiber M, Martin S, Kempf K Nutrients. 2020; 12(10).

PMID: 33007918 PMC: 7601801. DOI: 10.3390/nu12103004.


Impact of Two Different Reference Measurement Procedures on Apparent System Accuracy of 18 CE-Marked Current-Generation Blood Glucose Monitoring Systems.

Freckmann G, Baumstark A, Jendrike N, Mende J, Schauer S, Link M J Diabetes Sci Technol. 2020; 16(5):1076-1088.

PMID: 32814455 PMC: 9445332. DOI: 10.1177/1932296820948873.